(Q24248143)

1

0 references

P Mical

2

0 references

M van der Wetering

3

0 references

L Kremer

4

0 references

A Fraser

Cochrane Database of Systematic Reviews

5

0 references

publication date

21 July 2003

0 references

published in

0 references

cites work

Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute Leukemia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386

Prophylaxis with fluoroquinolones for bacterial infections in neutropenic patients: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386

The new fluorinated quinolones for antimicrobial prophylaxis in neutropenic cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386

From the Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386

Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386

Prevention of infections in the neutropenic patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386

7 January 2021

Ofloxacin versus trimethoprim-sulfamethoxazole for prevention of infection in patients with acute leukemia and granulocytopenia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386

7 January 2021

Strategy for antibiotic therapy in febrile neutropenic patients on selective antibiotic decontamination

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386

7 January 2021

Gram-positive bacteraemia in granulocytopenic cancer patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386

7 January 2021

Selective oral antimicrobial prophylaxis for the prevention of infection in acute leukaemia-ciprofloxacin versus co-trimoxazole plus colistin. The EORTC-Gnotobiotic Project Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386

7 January 2021

Antibacterial prophylaxis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386

7 January 2021

Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropenia.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386

7 January 2021

2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386

7 January 2021

The prophylaxis of bacterial infections in neutropenic patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386

7 January 2021

Use of fluoroquinolones as prophylactic agents in patients with neutropenia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386

7 January 2021

Outbreak of coagulase negative staphylococcus highly resistant to ciprofloxacin in a leukaemia unit

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386

7 January 2021

Efficacy of quinolone prophylaxis in neutropenic cancer patients: a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386

7 January 2021

Quinolone-Based Antibacterial Chemoprophylaxis in Neutropenic Patients: Effect of Augmented Gram-Positive Activity on Infectious Morbidity

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004386

7 January 2021